Peter V. Dicpinigaitis

8.9k citations

169 papers · 5.5k indexed · 3 hit papers · h-index 38

Pulmonary and Respiratory Medicine top 0.2%
Physiology top 0.5%
Emergency Medical Services top 0.1%
Gastroenterology top 0.5%
Sensory Systems top 0.5%

Co-authors: Lorcan McGarvey Alyn H. Morice Surinder S. Birring John A. Smith J. Dobkin Khalid Rauf Kian Fan Chung Maria G. Belvisi
Topics: Respiratory and Cough-Related Research (136 papers)Asthma and respiratory diseases (85 papers)Pediatric health and respiratory diseases (58 papers)
Cited by: Emergency Medical Services Physiology Sensory Systems
Journals: The LancetSHILAP Revista de lepidopterologíaJournal of the American College of Cardiology
Partner nations: United States United Kingdom Italy

In The Last Decade

Peter V. Dicpinigaitis

163 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ERS guidelines on the assessment of cough

2007 543 citations Alyn H. Morice, Giovanni Fontana et al. European Respiratory Journal profile →
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children

2019 475 citations Alyn H. Morice, Eva Millqvist et al. European Respiratory Journal profile →
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

2022 178 citations Lorcan McGarvey, Surinder S. Birring et al. profile →

Peers

Countries citing papers authored by Peter V. Dicpinigaitis

Since Specialization

Citations

This map shows the geographic impact of Peter V. Dicpinigaitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter V. Dicpinigaitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter V. Dicpinigaitis more than expected).

Fields of papers citing papers by Peter V. Dicpinigaitis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter V. Dicpinigaitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter V. Dicpinigaitis. The network helps show where Peter V. Dicpinigaitis may publish in the future.

Co-authorship network of co-authors of Peter V. Dicpinigaitis

This figure shows the co-authorship network connecting the top 25 collaborators of Peter V. Dicpinigaitis. A scholar is included among the top collaborators of Peter V. Dicpinigaitis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter V. Dicpinigaitis. Peter V. Dicpinigaitis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The McMaster Cough Severity Questionnaire (MCSQ): a cough severity instrument for patients with refractory chronic cough 2024 ·European Respiratory Journal ·Elena Kum,Gordon H. Guyatt,Rayid Abdulqawi,Peter V. Dicpinigaitis,Lieven Dupont,Stephen K. Field,Cynthia French,Peter G. Gibson,Richard S. Irwin,(unknown),Lorcan McGarvey,Robert A. Newman,(unknown),John A. Smith,Woo‐Jung Song,Paul M. O’Byrne,Imran Satia	0
2	Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study 2023 ·Lung ·Peter V. Dicpinigaitis,Alyn H. Morice,John A. Smith,Mandel Sher,Michael F. Vaezi,Laurent Guilleminault,Akio Niimi,Kerstin Gude,Ulrike Krahn,(unknown),Philippe Vieira Pires,(unknown),Lorcan McGarvey,(unknown)	24
3	S1 A phase 3b trial of gefapixant, a P2X3-receptor antagonist, in women with chronic cough and stress urinary incontinence 2023 ·SS Birring,L. Cardozo,Peter V. Dicpinigaitis,Roger R. Dmochowski,(unknown),Carmen La Rosa,Susan Lu,Allison Martin Nguyen,(unknown),(unknown)	1
4	Response in Patient-reported Cough Severity in Soothe, a Phase 2b Trial of Camlipixant in Refractory Chronic Cough 2023 ·Lorcan McGarvey,John A. Smith,Surinder S. Birring,Peter V. Dicpinigaitis,Mandel Sher,(unknown),(unknown),Lewis O. Harvey,(unknown),(unknown)	5
5	Reply to Weinberger 2023 ·American Journal of Respiratory and Critical Care Medicine ·Surinder S. Birring,Alyn H. Morice,Peter V. Dicpinigaitis,Lorcan McGarvey,Ian Pavord,Stuart A. Green,George Philip,John A. Smith	1
6	A Case Report and Literature Review of Babesiosis-Induced Acute Respiratory Distress Syndrome 2022 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Peter V. Dicpinigaitis,Johanna P. Daily,Louis M. Weiss,(unknown)	2
7	The current and emerging treatment landscape for chronic cough 2022 ·The American Journal of Managed Care ·Peter V. Dicpinigaitis	5
8	Prevalence and Burden of Chronic Cough in the United States 2021 ·The Journal of Allergy and Clinical Immunology In Practice ·Eli O. Meltzer,Robert S. Zeiger,Peter V. Dicpinigaitis,Jonathan A. Bernstein,John Oppenheimer,(unknown),Vicky W. Li,Robert Boggs,Michael J. Doane,(unknown),Jessica Weaver,Jonathan Schelfhout,Eileen Fonseca	65
9	Falsely Accused? Insufficient Evidence to Conclude that Sitagliptin is a Cause of Chronic Cough 2020 ·Lung ·Peter V. Dicpinigaitis,Imran Satia,(unknown)	8
10	Late-breaking abstract: Antitussive effect of a diphenhydramine-containing multicomponent cough syrup in acute viral cough 2014 ·European Respiratory Journal ·Peter V. Dicpinigaitis,(unknown),Amber E. Johnson,(unknown),J. O. Brew,Wilson Caparrós‐Wanderley	1
11	Antibiotic or symptomatic therapy in URTI-related pediatric acute cough? 2013 ·European Respiratory Journal ·Alessandro Zanasi,Luigi Lanata,Francesco De Blasio,(unknown),Giovanni Fontana,Rossella Balsamo,Peter V. Dicpinigaitis	1
12	Cough hypersentivity syndrome: Preliminary findings of the ERS taskforce 2013 ·European Respiratory Journal ·Alyn H. Morice,Kian Fan Chung,Peter V. Dicpinigaitis,Lorcan McGarvey,Eva Millqvist,Raimundas Sakalauskas,(unknown),Adalberto Pacheco,Surinder S. Birring,John A. Smith,Maria G. Belvisi,Lieven Dupont,(unknown),(unknown)	1
13	Age And Sex Distribution Of Patients Presenting To Specialist Cough Clinics 2013 ·American Journal of Respiratory and Critical Care Medicine ·Alyn H. Morice,Adam D Jakes,Shoaib Faruqi,Surinder S. Birring,Lorcan McGarvey,Brendan J. Canning,(unknown),(unknown),(unknown),(unknown),Stuart B. Mazzone,Ian Pavord,Peter V. Dicpinigaitis,(unknown)	2
14	Antibiotics in URTI-Related Acute Cough: Analysis of Two Studies in Children 2013 ·CHEST Journal ·Alessandro Zanasi,Luigi Lanata,Michela Bagnasco,(unknown),Peter V. Dicpinigaitis,Francesco De Blasio,Giovanni Fontana	0
15	Cough reflex sensitivity during acute viral upper respiratory tract infection (common cold) 2011 ·European Respiratory Journal ·Peter V. Dicpinigaitis,(unknown),D. Hull,Angela Qu	1
16	Effect of viral upper respiratory tract infection on the urge-to-cough sensation 2010 ·Respiratory Medicine ·Peter V. Dicpinigaitis,(unknown),(unknown),(unknown),Abdissa Negassa	53
17	Antitussive effects of leukotriene receptor antagonists 2002 ·European Respiratory Review ·Peter V. Dicpinigaitis	1
18	Cough Reflex Sensitivity in Subjects with Cervical Spinal Cord Injury 1999 ·American Journal of Respiratory and Critical Care Medicine ·Peter V. Dicpinigaitis,David R. Grimm,Marvin Lesser	29
19	Use of Baclofen to Suppress Cough Induced by Angiotensin-Converting Enzyme Inhibitors 1996 ·Annals of Pharmacotherapy ·Peter V. Dicpinigaitis	35
20	Hypertensive crises induced by treatment of malignant pheochromocytoma with a combination of cyclophosphamide, vincristine, and dacarbazine 1994 ·Medical and Pediatric Oncology ·(unknown),Peter V. Dicpinigaitis,Howard W. Bruckner,William M. Manger,Steven D. Averbuch	17

About Peter V. Dicpinigaitis

Peter V. Dicpinigaitis is a scholar working on Emergency Medical Services, Pulmonary and Respiratory Medicine and Physiology, having authored 169 papers that have together received 5.5k indexed citations. Recurring topics across this work include Respiratory and Cough-Related Research (136 papers), Asthma and respiratory diseases (85 papers) and Pediatric health and respiratory diseases (58 papers). The work is most often cited by research in Emergency Medical Services (1.1k citations), Physiology (3.6k citations) and Sensory Systems (665 citations). Peter V. Dicpinigaitis has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Lorcan McGarvey, Alyn H. Morice, Surinder S. Birring, John A. Smith, J. Dobkin, Khalid Rauf, Kian Fan Chung, Maria G. Belvisi, Giovanni Fontana and Eva Millqvist. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact